Metformin targets histone acetylation in cancer-prone epithelial cells
Cell Cycle. 2016 Dec 16;15(24):3355-3361. doi: 10.1080/15384101.2016.1249547.…
STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK-rearranged lung cancer
Cell Cycle. 2016 Dec 16;15(24):3413-3418. doi: 10.1080/15384101.2016.1245249.…
Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer
Histol Histopathol. 2017 Jul;32(7):687-698. doi: 10.14670/HH-11-830.…
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Curr Pharm Des. 2016;22(46):6935-6945. doi: 10.2174/1381612822666160923115828.ABSTRACTOver…
Translational research in neuroendocrine tumors: pitfalls and opportunities
Oncogene. 2017 Apr 6;36(14):1899-1907. doi: 10.1038/onc.2016.316.…
Cancer network activity associated with therapeutic response and synergism
Genome Med. 2016 Aug 24;8(1):88. doi: 10.1186/s13073-016-0340-x.ABSTRACTBACKGROUND:…
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional Cancer
Gastroenterology. 2016 Nov;151(5):961-972. doi: 10.1053/j.gastro.2016.08.001.…
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells
Oncotarget. 2016 Sep 13;7(37):59766-59780. doi: 10.18632/oncotarget.11121.ABSTRACTThe…
The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients
Oncotarget. 2016 Sep 13;7(37):60110-60122. doi: 10.18632/oncotarget.11076.ABSTRACTThe…
RANK Signaling Blockade Reduces Breast Cancer Recurrence by Inducing Tumor Cell Differentiation
Cancer Res. 2016 Oct 1;76(19):5857-5869. doi: 10.1158/0008-5472.CAN-15-2745.…
Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS One. 2016 Jul 27;11(7):e0158801. doi: 10.1371/journal.pone.0158801.…
Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer
Oncotarget. 2016 Aug 30;7(35):56295-56308. doi: 10.18632/oncotarget.10787.ABSTRACTAround,…
